20-47210799-G-A
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 3P and 4B. PM2PP2BP4_Strong
The NM_001281775.3(ZMYND8):c.3667C>T(p.Leu1223Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000131 in 1,614,100 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001281775.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZMYND8 | NM_001281775.3 | c.3667C>T | p.Leu1223Phe | missense_variant | 23/23 | ENST00000471951.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZMYND8 | ENST00000471951.7 | c.3667C>T | p.Leu1223Phe | missense_variant | 23/23 | 1 | NM_001281775.3 | A2 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152100Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000191 AC: 48AN: 251490Hom.: 0 AF XY: 0.000213 AC XY: 29AN XY: 135920
GnomAD4 exome AF: 0.000134 AC: 196AN: 1461882Hom.: 0 Cov.: 30 AF XY: 0.000157 AC XY: 114AN XY: 727244
GnomAD4 genome AF: 0.000105 AC: 16AN: 152218Hom.: 0 Cov.: 31 AF XY: 0.000108 AC XY: 8AN XY: 74416
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 28, 2023 | The c.3529C>T (p.L1177F) alteration is located in exon 23 (coding exon 23) of the ZMYND8 gene. This alteration results from a C to T substitution at nucleotide position 3529, causing the leucine (L) at amino acid position 1177 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at